DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia

Inclusion Criteria:

- A diagnosis of idiopathic CD as determined by the enrolling investigator

- If previously treated with a neurotoxin for CD, at least a 12-week interval must have
elapsed between the last injection of Botulinum toxin A (BoNT-A) or Botulinum toxin B
(BoNT-B) and the first dose of Dysport injected in this study

- Patient is able to comply with the protocol (e.g., can visit the clinic as required
and can complete questionnaires/telephone interviews)

- Provision of written informed consent prior to enrollment

Exclusion Criteria:

- Contraindications to treatment with any BoNT-A or BoNT-B preparations

- Based on Investigator opinion, patients in whom previous BoNT-A or BoNT-B therapy has
failed to produce a clinical response or produced an intolerable adverse reaction

- Anticipated concomitant treatment with BoNT for other than cervical dystonia

- Secondary cervical dystonia